
Dr. Ali Nuri Hünerlitürkoglu is a leading hematologist and oncologist in Germany, currently serving as the Chief of the Hematology and Internal Oncology Department at Helios Hospital Krefeld. With over 25 years of medical experience, he has earned a stellar reputation for his compassionate care and advanced clinical insight. Dr. Hünerlitürkoglu is known for blending modern oncology approaches with patient-focused treatment models, making him a top choice for cancer and blood disorder care. Fluent in English, German, and Russian, he provides services both in-person and online, ensuring global accessibility for international patients. His ability to offer remote consultations via video has further strengthened his role as a popular doctor in Germany. Patients value his personalized approach, in-depth consultations, and transparent communication. Whether in person or virtually, Dr. Hünerlitürkoglu remains committed to providing high-quality care tailored to each patient’s individual health needs.
Price upon request

Prof. Dr. Ernst Spath Schwalbe is a highly respected hematologist and oncologist in Germany, with expertise in palliative medicine and gastroenterology. With over 35 years of experience, he currently leads the Hematology and Oncology Department at Vivantes Spandau Hospital in Berlin. His specialties include treating T-cell Lymphoma, Hodgkin’s Disease, Leukemia, Aplastic Anemia, and Non-Hodgkin’s Lymphoma. A distinguished member of global oncology organizations, Prof. Dr. Spath Schwalbe is dedicated to advancing cancer treatment and patient care.
Price upon request

Dr. Herbert Sayer is a top oncohematologist in Germany known for his patient-focused approach and commitment to delivering advanced treatments in hematology and oncology. Practicing at Helios Hospital in Erfurt, Frankfurt, Dr. Sayer is widely regarded as one of the leading cancer specialists for complex chronic conditions. His personalized treatment plans and dual consultation system, both in-person and online, have made him a popular choice for patients seeking expert oncohematology care in Germany. Whether it's a direct hospital visit or a scheduled online consultation, Dr. Herbert Sayer ensures a high standard of care with efficient communication and thorough medical guidance. Patients can easily access his expertise remotely by submitting their medical documents and scheduling video consultations. This hybrid model of care reflects his dedication to accessible, reliable healthcare for both local and international patients. Dr. Herbert Sayer’s professional presence at a prestigious facility like Helios Hospital further strengthens his reputation as a famous oncohematologist in Frankfurt.
Price upon request

Dr. Stephen Fuhrmann is a renowned oncohematologist with over 40 years of experience in treating hematologic cancers. Practicing at the prestigious Helios Emil von Behring Hospital in Germany, Dr. Fuhrmann is widely recognized as one of the leading doctors in Hematology Oncology. He is well-versed in multiple languages, including Russian, German, and English, enabling him to serve a diverse international patient base. Dr. Fuhrmann is acclaimed for his compassionate approach and dedication to personalized patient care. To improve accessibility, he offers online consultations, allowing patients worldwide to receive expert advice by securely sharing medical documents and scheduling video consultations. With his advanced knowledge and decades of hands-on experience, Dr. Stephen Fuhrmann remains a top choice for patients seeking effective and advanced cancer treatment.
Price upon request

Dr. Eckhart Weidmann is a globally recognized expert in hematology and the Chief of the Hematology Unit at Nordwest Clinic. With over 30 years of experience, he has made remarkable contributions to diagnosing and treating blood disorders while advancing clinical research. His specialties include hematology, oncology, and immunology, and he offers comprehensive care for complex conditions. Through Best Clinic Abroad, patients can access his expertise for personalized consultations and advanced treatments.
Price upon request

Prof. Dr. Florian Bassermann is a highly respected expert in hematology and oncology and serves as the Director of the Clinic for Internal Medicine III at Rechts der Isar Hospital in Munich. His research focuses on understanding how certain types of cancer, such as blood cancers and lung cancer, grow and spread at the molecular level. He studies how disruptions in important cell processes, like DNA repair, immune responses, and cell death, can lead to cancer development.
Prof. Bassermann earned his medical degree from the Technical University of Munich (TUM) in 2002 after studying in Ulm, Munich, and New York. He further expanded his expertise through a postdoctoral fellowship at New York University from 2006 to 2009. After returning to Munich, he led a prestigious research group funded by the German Research Foundation and became board-certified in internal medicine and hematology/oncology.
In 2017, he became the Director of the oncology department at Rechts der Isar Hospital. Prof. Bassermann has received several awards for his contributions to cancer research, including the ERC Consolidator Grant and the Theodor Frerichs Prize. His work continues to improve the understanding and treatment of cancer, making a lasting impact on patient care and scientific progress.
Price upon request

Prof. Dr. Elke Jaeger stands as a distinguished figure among Germany's top medical professionals, renowned for her expertise as an onco-hematologist. Currently serving at the Nordwest Clinic in Germany, she boasts a wealth of experience in her field and holds an esteemed position as the Chairman of Interdisciplinary Oncology at Frankfurt's Goethe University. As an honorary member of prestigious medical organizations, Prof. Dr. Jaeger has dedicated herself to advancing the understanding and treatment of various disorders. Her specialization encompasses a spectrum of conditions, including leukemia, stem cell transplant, lymphoma, immunotherapy, and anemia. Beyond her clinical responsibilities, Prof. Dr. Elke Jaeger actively contributes to the realm of experimental oncology, spearheading clinical trials and managing innovative approaches to treating malignant disorders with pharmaceuticals. Notably, she extends her influence beyond Germany, serving as a professor at the Roswell Park Cancer Center in the United States. Prof. Dr. Jaeger's commitment to the next generation of medical professionals is evident through her contributions to practical year training courses for students at Johann Wolfgang Goethe University. Her multifaceted contributions to the field underscore her dedication to advancing medical knowledge and enhancing patient care.
Price upon request

Dr. Marc Schmidt-Supprian is a distinguished hematologist and immunologist with over 20 years of experience diagnosing and treating complex blood disorders and immune system conditions. He is the Head of the Hematology Center at Rechts der Isar Hospital in Munich, Germany. He is also a professor at the Technical University of Munich, where he leads the Institute for Experimental Hematology.
Dr. Schmidt-Supprian began his academic journey studying chemistry and biochemistry at the Universities of Würzburg and Tübingen and Trinity College Dublin. He earned his doctorate in 2003 under the guidance of Professor Klaus Rajewsky at the University of Cologne and Harvard Medical School. Following his doctoral studies, he completed a postdoctoral fellowship and held a faculty position at Harvard Medical School until 2007. In late 2007, he established a prestigious DFG Emmy Noether research group at the Max Planck Institute of Biochemistry and later became a Tenure Track Professor at the Technical University of Munich in 2014.
At Rechts der Isar Hospital, Dr. Schmidt-Supprian offers personalized consultations and advanced treatments tailored to each patient’s unique needs. For added convenience, patients can access his expertise through Best Clinic Abroad, an official partner, providing seamless assistance for scheduling consultations and coordinating medical records.
Dr. Marc Schmidt-Supprian’s extensive expertise, coupled with his dedication to innovation and compassionate care, makes him a trusted name in hematology and immunology. Patients can easily arrange consultations with him through Best Clinic Abroad, ensuring smooth coordination and access to world-class medical advice.
Price upon request

Prof. Dr. Ulrich Duehrsen is a top hematologist in Germany, recognized for his outstanding contributions in internal medicine, hematology, and oncology. With over 24 years of experience, he leads the prestigious Department of Hematology at University Hospital Essen, one of Europe’s premier cancer centers. As a famous doctor in Germany, he plays a vital role in providing patient-centric care through innovative and interdisciplinary approaches. His leadership ensures that over 16,000 patients each year receive cutting-edge therapies for blood cancers and hematopoietic diseases. Fluent in English, German, and Russian, Prof. Duehrsen is internationally accessible and offers both inpatient and outpatient care. Patients benefit not only from his clinical expertise but also from access to clinical trials and research-based treatments. Known for his commitment to excellence, Prof. Dr. Ulrich Duehrsen has become one of the most popular hematologists in Europe, offering unparalleled care through precision and compassion.
Price upon request

Prof. Dr. Wolfgang Janni, with 23 years of experience, is a senior consultant at the Gynecology and Obstetrics Center at Ulm University Hospital. Renowned for his expertise in Oncology, Breast Cancer, and Reproductive Medicine, Dr. Janni is dedicated to providing exceptional care to his patients. He offers both in-person and online consultations, ensuring accessibility and personalized support. For online sessions, patients can submit their medical records, contact Best Clinic Abroad, and schedule a video consultation, combining convenience with expert medical guidance.
Price upon request
Hematologic malignancies and complex blood disorders represent a significant and growing global health burden. According to data from international cancer authorities and the World Health Organization, conditions such as leukemia, lymphoma, multiple myeloma, and related bone marrow disorders account for a substantial proportion of cancer-related morbidity worldwide. Advances in diagnostics and treatment have improved survival in many cases, but they have also increased the need for highly specialized physicians trained in both hematology and oncology. Hematologists-oncologists play a central role in diagnosing, treating, and coordinating long-term care for patients with cancers of the blood and lymphatic system, as well as selected solid tumors and non-malignant hematologic conditions.
Germany is widely recognized for its structured, regulation-driven healthcare system, which places strong emphasis on patient safety, evidence-based practice, and continuous quality oversight. Cancer care in Germany is delivered through a network of university hospitals, certified cancer centers, and specialized departments that adhere to national standards issued by professional medical societies and federal regulatory bodies. These standards are closely aligned with international clinical guidelines developed by organizations such as the European Society for Medical Oncology and other globally recognized authorities.
In recent years, hematology-oncology care in Germany has continued to evolve through the integration of molecular diagnostics, multidisciplinary tumor boards, and personalized treatment planning. German centers routinely use standardized care pathways that emphasize accurate diagnosis, careful risk stratification, and shared decision-making between clinicians and patients. Psychological and supportive care services are commonly incorporated into treatment programs, recognizing the emotional and social impact of cancer and chronic blood disorders.
From an international patient perspective, Germany’s healthcare infrastructure offers transparency in clinical governance, predictable regulatory oversight, and access to tertiary-level facilities. While costs are generally higher than in some regions, they reflect the complexity of care, advanced infrastructure, and specialist expertise involved. Overall, hematologists-oncologists in Germany are valued for their methodical approach, adherence to clinical standards, and focus on individualized, patient-centered care rather than uniform treatment models.
The following physicians are well-established hematologists-oncologists practicing in major German academic or tertiary-care institutions. The listings below are informational and do not represent rankings or endorsements.
Prof. Dr. Michael Hallek, MD
Specialization: Hematology and Medical Oncology, with a focus on lymphoid malignancies
Years of Experience: Over 30 years
Clinical Focus: Prof. Hallek is known for his long-standing involvement in the diagnosis and management of chronic lymphocytic leukemia and related disorders. His work emphasizes guideline-based therapy, clinical research integration, and multidisciplinary decision-making. He practices at the University Hospital of Cologne, a major academic medical center with certified oncology programs.
Prof. Dr. Andreas Engert, MD
Specialization: Hematology-Oncology, particularly lymphoma care
Years of Experience: Over 25 years
Clinical Focus: Prof. Engert’s clinical work centers on Hodgkin and non-Hodgkin lymphomas, with an emphasis on evidence-based treatment protocols and long-term outcome monitoring. He is affiliated with the University Hospital of Cologne, where hematology-oncology services are integrated with translational research and supportive care units.
Prof. Dr. Ulrich Germing, MD
Specialization: Hematology with a focus on myelodysplastic syndromes
Years of Experience: Over 25 years
Clinical Focus: Prof. Germing specializes in bone marrow disorders, including myelodysplastic syndromes and related conditions. His practice at Heinrich Heine University Hospital Düsseldorf involves detailed diagnostic evaluation, risk-adapted management strategies, and collaboration with transplant and laboratory medicine teams.
Prof. Dr. Albrecht Reichle, MD
Specialization: Medical Oncology and Hematology
Years of Experience: Over 30 years
Clinical Focus: Prof. Reichle’s work focuses on systemic cancer therapies, including hematologic malignancies and solid tumors. He practices at the University Hospital Regensburg, where care is delivered within certified oncology centers emphasizing interdisciplinary coordination and adherence to national treatment guidelines.
| Consultation Type | Estimated Cost Range (USD) |
| Hematologists-Oncologists consultation | $250-$600 |
Note: Costs are approximate and provided for general guidance only. Prices vary depending on the healthcare provider, hospital type, city, and consultation format (in-person or remote). Diagnostic tests, imaging, or additional evaluations are not included. Final fees are determined by the provider after an individual clinical assessment and may be affected by currency fluctuations.
Choosing to seek specialist care in another country can feel complex and sometimes overwhelming, especially when dealing with serious conditions such as cancer or chronic blood disorders. Many patients and families look for healthcare systems that offer clarity, structure, and strong clinical oversight. Germany is often considered because of its methodical approach to specialist care and well-defined medical standards.
➤ Availability of English-speaking medical staff and professional medical translators in many facilities
➤ Specialized clinics that manage a high volume of international patients
➤ Government regulations and oversight mechanisms supporting medical tourism safety and international patient protection
➤ Structured hospital documentation, patient-safety protocols, and informed consent practices
For international patients, it is important to understand practical considerations alongside clinical care. Visa or entry requirements depend on nationality and length of stay and should be confirmed well in advance. When treatment involves intensive therapy or recovery periods, a postoperative or post-treatment stay of at least 7-14 days in Germany may be required, depending on the clinical situation. While major cities and university hospitals commonly offer English-language support, language barriers may still arise outside large centers. Planning for continuity of care after returning home, including follow-up appointments and communication with local physicians, is an essential part of responsible treatment planning.
Patients considering hematologists-oncologists in Germany can share their medical reports with Best Clinic Abroad to receive coordinated support, guidance on consultation options, and assistance in understanding how to begin the care planning process with appropriate specialists.
How many oncologists are there in Germany?
Germany has several thousand practicing oncologists, including medical oncologists and hematologists-oncologists, working across university hospitals, certified cancer centers, and regional hospitals. These physicians are distributed throughout the country, with higher concentrations in major cities and academic medical centers. The exact number changes over time due to training, retirement, and subspecialization, but Germany maintains a robust oncology workforce relative to its population.
What is the best oncology hospital in Germany?
There is no single “best” oncology hospital in Germany, as care quality depends on the type of cancer, available subspecialists, and individual patient needs. Many university hospitals and certified comprehensive cancer centers are internationally recognized for their adherence to clinical guidelines, multidisciplinary care models, and research integration. For you, the most appropriate hospital is typically one that has documented experience with your specific condition and offers coordinated, guideline-based care.
Disclaimer
“This content is provided for informational purposes only and does not constitute medical advice. Diagnosis and treatment decisions should be made in consultation with a licensed medical specialist based on individual clinical evaluation.”